Publicaciones en colaboración con investigadores/as de Cancer Registry of Norway (37)

2022

  1. MirGeneDB 2.1: toward a complete sampling of all major animal phyla

    Nucleic acids research, Vol. 50, Núm. D1, pp. D204-D210

2019

  1. Association of menopausal characteristics and risk of coronary heart disease: A pan-European case-cohort analysis

    International Journal of Epidemiology, Vol. 48, Núm. 4, pp. 1275-1285

  2. Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study

    European Journal of Nutrition, Vol. 58, Núm. 8, pp. 3303-3312

2018

  1. Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

    International Journal of Cancer, Vol. 142, Núm. 3, pp. 449-459

  2. Nutritional quality of food as represented by the FSAm-NPS nutrient profiling system underlying the Nutri-Score label and cancer risk in Europe: Results from the EPIC prospective cohort study

    PLoS Medicine, Vol. 15, Núm. 9

  3. Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

    International Journal of Cancer, Vol. 143, Núm. 10, pp. 2351-2358

  4. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies

    The Lancet, Vol. 391, Núm. 10129, pp. 1513-1523

2017

  1. Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition

    International Journal of Cancer, Vol. 140, Núm. 10, pp. 2246-2255

  2. Consumption of fish is not associated with risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition (EPIC) study

    Journal of Nutrition, Vol. 147, Núm. 7, pp. 1366-1373

  3. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  4. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

2015

  1. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

    The Lancet, Vol. 385, Núm. 9972, pp. 977-1010

2014

  1. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study

    The Lancet Oncology, Vol. 15, Núm. 1, pp. 23-34

  2. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

    Cancer Epidemiology, Vol. 38, Núm. 6, pp. 670-678

2013

  1. Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project

    European Journal of Cancer, Vol. 49, Núm. 3, pp. 684-695

  2. Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project

    European Journal of Cancer, Vol. 49, Núm. 11, pp. 2565-2578

2012

  1. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe

    European Journal of Cancer, Vol. 48, Núm. 2, pp. 159-169

  2. Carcinoma of endocrine organs: Results of the RARECARE project

    European Journal of Cancer, Vol. 48, Núm. 13, pp. 1923-1931

  3. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe

    European Journal of Cancer, Vol. 48, Núm. 8, pp. 1167-1175

  4. Embryonal cancers in Europe

    European Journal of Cancer, Vol. 48, Núm. 10, pp. 1425-1433